ClinConnect ClinConnect Logo
Search / Trial NCT06817551

Comparison of Outcomes of Management of Bowel Obstruction Pilot Study

Launched by UNIVERSITY OF WASHINGTON · Feb 4, 2025

Trial Information

Current as of July 01, 2025

Enrolling by invitation

Keywords

Asbo Sbo Small Bowel Obstruction Dexamethasone

ClinConnect Summary

Millions of Americans each year experience adhesion-related small bowel obstruction (aSBO), a condition associated with significant morbidity and prolonged hospitalization. Adhesions formed after previous abdominopelvic surgery can cause twisting of the bowel resulting in injury and a cascade of inflammation that results in progressive bowel wall edema with narrowing of the bowel lumen. This leads to or worsens the bowel obstruction. Reversing this inflammation has the potential to reduce the severity and impact of aSBO, hasten the return of bowel function and avoid an emergency operation t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults ≥18 years of age recruited from UWMC
  • Patients presenting to surgical services through the Emergency Department, diagnosis of SBO, consulted by surgeon, and an urgent or emergency operation is deemed not necessary by surgeon.
  • Diagnosis of aSBO is established by;
  • 1. CT findings consistent with diagnosis of SBO; and
  • 2. signs and symptoms consistent with SBO; and
  • 3. Adhesions are the likely cause of SBO (absence of incarcerated hernia, internal hernia, masses, fistula, stricture, volvulus, acute episode of inflammatory bowel disease (IBD) flare, etc.).
  • Ability to provide written or electronic informed consent in English and answer teach-back questions
  • Exclusion Criteria:
  • Signs and symptoms of peritonitis with emergency operation planned
  • Planned urgent operation within the next 12 hours
  • Allergy to dexamethasone
  • Surgery within prior 6 weeks
  • Unable or unwilling to return or be contacted for and/or complete research surveys
  • Currently incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening
  • Individuals with latent infections who have an increased risk of infection.

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

David Flum, MD, MPH

Principal Investigator

University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported